Literature DB >> 29297762

Healthy China 2030, a breakthrough for improving health.

Xiaodong Tan1, Yanan Zhang1, Haiyan Shao1.   

Abstract

China has the largest population in the world, and its health levels have greatly affected the healthy development of the population of the world. Healthy China 2030 is a breakthrough for ensuring that the Chinese population have access to health, through advocating the whole society's participation in the concept of "Health for All, and All for Health." The plan puts forward five strategies such as popularizing healthy life, optimizing the health service, improving health protection, building a healthy environment, and developing healthy industry, from the perspectives of health effects of personal life and behavior, health care and security, production, and the living environment. As a national guide for public health promotion, we briefly describe the main intentions of Healthy China 2030, and give some commentaries from a health promotion perspective.

Keywords:  global health/globalization; health promotion; healthy cities/healthy communities

Year:  2018        PMID: 29297762     DOI: 10.1177/1757975917743533

Source DB:  PubMed          Journal:  Glob Health Promot        ISSN: 1757-9759


  37 in total

1.  Peer support in Shanghai's Commitment to diabetes and chronic disease self-management: program development, program expansion, and policy.

Authors:  Yuexing Liu; Xiaoyu Wu; Chun Cai; Patrick Y Tang; Muchieh Maggy Coufal; Yiqing Qian; Samantha Ling Luu; Edwin B Fisher; Weiping Jia
Journal:  Transl Behav Med       Date:  2020-02-03       Impact factor: 3.046

2.  Quality evaluation of HPV vaccine-related online messages in China: a cross-sectional study.

Authors:  Wanzhou Wang; Jinliang Lyu; Mintao Li; Yunjing Zhang; Zhihu Xu; Yuanyuan Chen; Jiangjie Zhou; Shengfeng Wang
Journal:  Hum Vaccin Immunother       Date:  2020-10-15       Impact factor: 3.452

3.  Elevated Serum Ninjurin-1 Is Associated with a High Risk of Large Artery Atherosclerotic Acute Ischemic Stroke.

Authors:  Nan Dong; Xuan Wu; Ting Hong; Xiaozhu Shen; Xianghong Guo; Hui Wang; Liqiang Yu; Hongru Zhao; Qi Fang
Journal:  Transl Stroke Res       Date:  2022-10-07       Impact factor: 6.800

4.  Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study.

Authors:  Shuxia Qin; Xuehong Wang; Sini Li; Chongqing Tan; Xiaohui Zeng; Xia Luo; Lidan Yi; Liubao Peng; Meiyu Wu; Ye Peng; Liting Wang; Xiaomin Wan
Journal:  Pharmacoeconomics       Date:  2022-06-15       Impact factor: 4.558

5.  Population Attributable Risks of Potential Modifiable Factors for Atrial Fibrillation in China: A National Survey.

Authors:  Zhiqiang Nie; Hongbin Xu; Chen Chen; Yong Gan; Guo Chen; Chao Wang; Wei Yue; Feng Yan; Yingqing Feng; Zuxun Lu
Journal:  Risk Manag Healthc Policy       Date:  2022-06-14

6.  Awareness of initiative practice for health in the Chinese population: A questionnaire survey based on a network platform.

Authors:  Yi-Qiang Zhang; Ming-Yue Zhou; Meng-Yang Jiang; Xiao-Yu Zhang; Xin Wang; Bao-Guo Wang
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

7.  Evaluating the vaccination coverage: validity of household-hold vaccination booklet and caregiver's recall.

Authors:  Yu Hu; Hu Liang; Fuxing Chen; Linzhi Shen; Xuejiao Pan; Ying Wang; Yaping Chen; Huakun Lv
Journal:  Hum Vaccin Immunother       Date:  2021-04-07       Impact factor: 3.452

8.  Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic.

Authors:  Weiwei Ping; Jianzhong Zheng; Xiaohong Niu; Chongzheng Guo; Jinfang Zhang; Hui Yang; Yan Shi
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

9.  Patterns and changes in life expectancy in China, 1990-2016.

Authors:  Hai Chen; Yun Qian; Yunqiu Dong; Zhijie Yang; Liangliang Guo; Jia Liu; Qian Shen; Lu Wang
Journal:  PLoS One       Date:  2020-04-01       Impact factor: 3.240

10.  Tackling Dialysis Burden around the World: A Global Challenge.

Authors:  Philip Kam-Tao Li; Gordon Chun-Kau Chan; Jianghua Chen; Hung-Chun Chen; Yuk-Lun Cheng; Stanley L-S Fan; John Cijiang He; Weixin Hu; Wai-Hon Lim; York Pei; Boon Wee Teo; Ping Zhang; Xueqing Yu; Zhi-Hong Liu
Journal:  Kidney Dis (Basel)       Date:  2021-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.